Find the right
clinical scale
52 validated tools · 13 clinical domains · DSM-5 aligned
Browse by domain
Commonly used
Full library
49 toolsADHD & Attention
4ADHD Clinical Outcome Scale – Self Report (ACOS-SR)
The ADHD Clinical Outcome Scale – Self-Report (ACOS-SR) is a brief 6-item measure developed to assess current ADHD symptom burden and functional impact in adults. It is derived from the clinician-rated ACOS and provides a rapid way to track treatment response, day-to-day functioning, and changes over time. Each item reflects core ADHD-related impairments commonly experienced in adulthood, including attention difficulties, distractibility, organization challenges, follow-through, impulsivity, and associated functional disruption. The ACOS-SR produces a single severity score ranging from 0 to 18. Initial validation work suggests that scores of 9 or higher may indicate clinically significant levels of ADHD-related impairment, though interpretation should always be integrated with clinical judgment.
ADHD Screening
World Health Organization-validated 18-question ADHD screening for adults. Part A/B scoring and tracking. Part A: 68.7% sensitivity, 99.5% specificity (Kessler et al.).
Strengths and Weaknesses of ADHD Symptoms and Normal Behavior Scale
An 18-item dimensional rating scale assessing ADHD symptoms in the context of normal behavioral variation. Rated on a bipolar scale from far below average to far above average. Appropriate for children, adolescents, and adults; available in parent, teacher, and self-report formats.
Wender Utah Rating Scale
Retrospective childhood ADHD assessment. Adults rate symptoms from ages 5–10 to establish the early onset required for a DSM-5-TR ADHD diagnosis.
Anxiety
3GAD-7 Scoring
GAD-7 scoring: total 0–21. Cutoffs: mild ≥5, moderate ≥10, severe ≥15. Sensitivity 89% at ≥10. Co-administer with PHQ-9 for anxiety and depression screening.
SCARED (Child Anxiety Screen)
SCARED anxiety scale calculator for children and adolescents: 41-item screener covering Panic, GAD, Separation Anxiety, Social Anxiety, and School Avoidance. Score ≥25 indicates possible anxiety disorder.
Screen for Child Anxiety Related Disorders – Parent Version
A 41-item parent-report version of the SCARED that assesses anxiety disorder symptoms in children and adolescents as observed by caregivers. Parallel to the child self-report SCARED; used together for multi-informant anxiety assessment.
Depression & Mood
4DASS-21 Scoring Calculator
DASS-21 scoring calculator with severity bands. ×2 multiplier applied automatically. Depression, anxiety, and stress subscales with cutoffs. Compare with PHQ-9 and GAD-7.
Patient Health Questionnaire Somatic Symptoms
15-item somatic symptom severity scale from the PHQ family. Score 0–30 across four bands: minimal, low, medium, high. Widely used for somatic symptom burden screening.
Patient Health Questionnaire – Depression Scale
An 8-item self-report measure of depression severity derived from the PHQ-9 by omitting the suicidality item. Validated for population-based research and clinical settings where suicidal ideation screening is conducted separately.
Patient Health Questionnaire-9
Standard instrument for screening, monitoring and measuring the severity of depression. 9-item scale aligned with DSM-5-TR criteria.
Dissociation
2Dissociative Experiences Scale, Brief (DES-B)
The Dissociative Experiences Scale–Brief (DES-B) is an 8-item short form derived from the original 28-item Dissociative Experiences Scale (DES). Developed to offer a rapid, clinically efficient way to screen for dissociation, the DES-B measures the frequency of common dissociative phenomena such as depersonalization, derealization, memory gaps, and absorption. Each item is rated from 0–100%, and the total score is the average of all responses. Research shows that the DES-B retains strong alignment with the full DES while dramatically reducing completion time, making it ideal for busy clinical settings where dissociation is suspected. The DES-B does not diagnose dissociative disorders but can help identify when further trauma-informed assessment is warranted.
Multidimensional Inventory of Dissociation (MID) : Clinician Scoring Guide
The MID (Version 6.0) is a comprehensive self-report measure designed to assess pathological dissociation across a wide range of symptoms, experiences, and internal phenomena. Developed by Paul F. Dell, PhD, the MID evaluates both severity and structure of dissociative experiences, including amnesia, depersonalization, derealization, identity alteration, voice hearing, trance states, and other dissociative phenomena commonly seen in trauma-related disorders. It produces 23 primary clinical scales, 10 validity indices, and two global summary scores: DIS-S (Severity of Dissociation) and DIS-T (Trait Dissociation). The MID is one of the most detailed dissociation assessments available and is frequently used in complex trauma, OSDD, and DID evaluations. Interpretation requires clinical expertise.
Functional & Quality of Life
8Assessment of Recovery Capital (ARC)
The Assessment of Recovery Capital (ARC) is a comprehensive, 50-item measure designed to evaluate the internal and external resources that support sustained substance-use recovery. Developed by Groshkova, Best, and White (2013), the ARC assesses two broad domains: Personal Recovery Capital and Social Recovery Capital. Together, these domains capture the psychological, physical, interpersonal, and community-level assets shown to protect against relapse and facilitate long-term wellbeing. The ARC provides a detailed profile of strengths and needs across multiple dimensions, making it useful for treatment planning, progress monitoring, and recovery-oriented care. It does not diagnose substance-use disorders, but it offers clinicians a structured, evidence-based framework for understanding the assets that help individuals maintain recovery.
Brief Assessment of Recovery Capital (BARC-10)
The Brief Assessment of Recovery Capital (BARC-10) is a short, validated measure designed to assess the internal and external resources that support sustained recovery from substance use. Adapted from the original 50-item Assessment of Recovery Capital (ARC), the BARC-10 captures the essential elements of personal growth, social connection, stability, and wellbeing associated with long-term recovery. Unlike deficit-based substance-use tools, the BARC-10 focuses on strengths and protective factors. Its single total score provides a quick overview of how well-resourced an individual is in their recovery journey. It does not diagnose substance-use disorders but offers clinicians a structured way to understand recovery readiness, resilience, and areas where support may be needed.
Devereux Adult Resilience Survey (DARS)
The Devereux Adult Resilience Survey (DARS) is a 36-item self-assessment designed to measure protective factors that support emotional well-being, resilience, and healthy functioning in adults. Developed by the Devereux Center for Resilient Children (DCRC), the DARS emphasizes strengths rather than symptoms, allowing individuals and clinicians to identify internal and external resources that promote adaptability and recovery. The survey produces a total resilience score along with four domain scores: Internal Beliefs, Relationships, Initiative, and Self-Control. These domains reflect core components of adult resilience within the DCRC’s research-based protective factors framework. The DARS is intended for strengths-based assessment, personal development, coaching, behavioral health, wellness programs, and organizational contexts rather than diagnosis.
Instrumental Activities of Daily Living Scale
An 8-item clinician-rated or self-report scale assessing functional independence in complex daily activities such as managing finances, medication, transportation, and housekeeping. Originally developed by Lawton & Brody (1969) for older adult populations.
Informant Questionnaire on Cognitive Decline in the Elderly – Self Report (IQCODE-SR)
The IQCODE-SR is the self-report adaptation of the widely used Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE). While the original IQCODE is completed by a knowledgeable informant, the IQCODE-SR allows older adults to report on their perceived cognitive changes over the past 10 years. Items cover everyday memory, reasoning, problem-solving, and functional abilities. Respondents rate whether each ability has improved, stayed the same, or worsened, producing a mean score between 1.0 and 5.0. Higher scores indicate greater perceived decline. Research-based thresholds (e.g., ≥3.30–3.38 for possible cognitive decline; ≥3.60 for stronger concern) provide guidance for further evaluation, but the IQCODE-SR is a screening tool, not a diagnostic assessment.
Return-to-Work Self-Efficacy Questionnaire
An 11-item self-report measure assessing a worker's confidence in their ability to return to work while managing health-related symptoms. Used in occupational rehabilitation and sick-leave management for anxiety, depression, and chronic pain.
SWLS (Satisfaction with Life Scale)
SWLS: 5-item global life satisfaction scale, score 5–35 across seven interpretation bands. Items rated 1–7. Diener et al. (1985).
World Health Organization Quality of Life – BREF (WHOQOL-BREF)
The WHOQOL-BREF is a 26-item self-report instrument developed by the World Health Organization to assess overall quality of life and subjective wellbeing across four key domains: physical health, psychological health, social relationships, and environment. It is used internationally in clinical, public health, and research settings. The WHOQOL-BREF is an assessment tool that measures quality of life across various domains. It is designed for individuals seeking to evaluate their well-being and is useful for identifying areas for improvement.
Neurodivergence & Autism
5Autism Spectrum Quotient (AQ)
The Autism Spectrum Quotient (AQ) is a 50-item self-report questionnaire designed by the Autism Research Centre (ARC) at the University of Cambridge to quantify the degree to which adults exhibit traits associated with Autism Spectrum Condition. The AQ is not a diagnostic assessment; instead, it provides a structured trait profile across five cognitive–behavioral domains commonly associated with autism: Social Skills, Attention Switching, Attention to Detail, Communication, and Imagination. Scores range from 0 to 50, with higher scores indicating more autistic traits. Research suggests that scores 26 or higher reflect elevated autistic characteristics, while 32 or higher aligns with traditional research cutoff values. The AQ is widely used in screening, psychoeducation, research, and clinical triage.
Autism Spectrum Quotient – Brief (AQ-10)
The AQ-10 is a brief 10-item autism trait screener developed as a shortened version of the full 50-item Autism Spectrum Quotient (AQ). Its purpose is rapid identification of individuals who may benefit from a full autism assessment. Each item reflects a high-discriminating question drawn from the original AQ domains: Social Skills, Communication, Attention Switching, Attention to Detail, and Imagination. Scores range from 0–10, with 6 or more recommended by NICE as the threshold for referral for a comprehensive autism assessment. The AQ-10 is not a diagnostic tool but serves as an efficient “red flag” screener suitable for busy clinical environments.
Childhood Autism Spectrum Test
A 37-item parent-report screening tool for autism spectrum characteristics in children aged 4–11. Designed for population-level screening; a score ≥15 indicates further evaluation is warranted.
CAT-Q
25-item autism masking scale. Learn how the CAT-Q identifies camouflaging behaviors, subscale scoring, and why high scores indicate burnout risk.
80-Item Adult Autism Screen + Scoring (Cutoff ≥65)
RAADS-R test (Ritvo Autism Asperger Diagnostic Scale-Revised): 80-item self-report adult autism screen. Cutoff ≥65 indicates autism traits warrant clinical evaluation. Four subscales: Language, Social Relatedness, Sensory/Motor, Circumscribed Interests. Ritvo et al. (2011). Educational only — not a diagnosis.
OCD & Compulsive Behaviors
3Children's Florida Obsessive Compulsive Inventory
A brief self-report measure of OCD symptom severity in children and adolescents aged 7–17. Comprises a symptom checklist and a 5-item severity scale.
Dimensional Obsessive-Compulsive Scale
A 20-item self-report measure assessing OCD severity across four symptom dimensions: contamination, responsibility for harm, unacceptable intrusive thoughts, and symmetry/ordering.
Florida Obsessive Compulsive Inventory
A brief self-report measure for adults comprising a symptom checklist and a 5-item severity scale. Quick to administer and sensitive to treatment change. A severity score ≥8 suggests clinically significant OCD.
Risk & Safety
2Columbia-Suicide Severity Rating Scale
The FDA-recommended criterion standard for suicide risk assessment, identifying severity and intensity of suicidal ideation and behavior.
Suicidal Ideation Attributes Scale (SIDAS)
The SIDAS is a 5-item self-report tool used to assess the severity and functional impact of suicidal thoughts. It was developed to support early identification and risk monitoring in community and clinical settings, particularly among individuals experiencing depression or distress. The Suicidal Ideation Attributes Scale (SIDAS) is an assessment tool designed to measure the severity of suicidal thoughts. It is intended for individuals experiencing suicidal ideation and is useful for mental health professionals to evaluate risk levels and plan interventions.
Substance Use
10AUDIT Scoring
AUDIT: World Health Organization 10-item alcohol screen. Score 0–40: low risk (0–7), hazardous (8–15), harmful (16–19), dependence (≥20). Sensitivity 92%, specificity 94%.
Alcohol, Smoking and Substance Involvement Screening Test (ASSIST v3.1)
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST v3.1) is a comprehensive screening tool developed by the World Health Organization (World Health Organization) to identify substance use and categorize risk levels across multiple substance classes. It evaluates recent use, cravings, health/social/legal consequences, and prior attempts to control use. The ASSIST provides a standardized Substance Involvement (SI) Score for each substance, allowing clinicians to differentiate low-, moderate-, and high-risk patterns. These SI scores support early detection, brief intervention planning, and referral pathways for specialized care when needed. While widely used in primary care, mental health, and substance-use settings, the ASSIST is a screening tool, not a diagnostic instrument.
Brief Biosocial Gambling Screen
The Brief Biosocial Gambling Screen (BBGS) is a 3-item validated tool designed to identify disordered gambling symptoms in clinical settings.
Adolescent Substance Use Screening Tool
6-item AAP-recommended screener for adolescent alcohol and drug use (ages 12–21). Score ≥2 is a positive screen for high-risk substance use or a substance use disorder.
E-Cigarette Dependence Scale
20-item measure of e-cigarette and vaping dependence severity. Assesses five subscales including craving and compulsive use. Morean et al. (2019).
Internet Gaming Disorder Scale – Short Form (IGDS9-SF)
The IGDS9-SF is a 9-item self-report tool that assesses the severity of Internet Gaming Disorder (IGD) symptoms based on the DSM-5-TR criteria. It is widely used to screen for problematic gaming behavior and support early identification of gaming-related functional impairment. The Internet Gaming Disorder Scale – Short Form (IGDS9-SF) is a tool designed to assess the severity of internet gaming disorder symptoms.
MAST (Michigan Alcohol Screening Test)
25-item validated yes/no screening tool for alcohol use disorder with weighted scoring. Score 0–53; ≥5 indicates probable alcoholism. Public domain. Selzer (1971).
Pain Medication Questionnaire (PMQ)
PMQ scoring guide. Pain Medication Questionnaire — 26-item opioid misuse risk screen for chronic pain. Score ≥23 = elevated risk. Adams et al. 2004.
South Oaks Gambling Screen
A 20-item self-report screening tool for pathological gambling, developed by Lesieur & Blume (1987). Scores ≥5 indicate probable pathological gambling. Widely used in both clinical and research settings.
Tobacco, Alcohol, Prescription medications, and other Substance use Tool (TAPS)
The TAPS Tool is a two-part screening and brief assessment instrument used to identify substance use and substance use disorders in adults. It covers tobacco, alcohol, prescription medications, and illicit drugs, and is designed for use in primary care and general medical settings. The TAPS tool assesses the use of tobacco, alcohol, prescription medications, and other substances. It's designed for healthcare providers to identify and address substance use in patients effectively.
Trauma & PTSD
4ACE Score
ACE score quiz: 10-category adverse childhood experiences questionnaire with automated scoring and clinical interpretation. Based on the Kaiser-CDC ACE Study.
Life Events Checklist for DSM-5-TR (LEC-5) and Criterion A
The LEC-5 is a brief, structured checklist developed by the National Center for PTSD to document exposure to potentially traumatic events. It is designed to support clinical evaluation of PTSD by identifying experiences that may meet DSM-5-TR Criterion A, the requirement for a qualifying trauma. Rather than measuring symptoms or severity, the LEC-5 maps the types and modes of exposure an individual has encountered, including direct experience, witnessing, learning of events affecting close others, or work-related exposure. The LEC-5 is typically administered alongside the PCL-5 or CAPS-5 and plays an important role in determining whether PTSD symptoms can be evaluated within the appropriate diagnostic framework.
PTSD Checklist for DSM-5-TR
A validated 20-item self-report measure assessing the 20 DSM-5-TR symptoms of PTSD over the past month.
Primary Care PTSD Screen for DSM-5-TR (PC-PTSD-5)
The PC-PTSD-5 is a brief, highly sensitive screening instrument designed to identify probable PTSD in primary care and general medical settings. Developed by Prins, Bovin, Smolenski, and colleagues (2016), this 5-item tool reflects DSM-5-TR PTSD criteria and focuses on intrusion, avoidance, cognitive/mood changes, and arousal. Its simplicity allows rapid identification of individuals who may benefit from a fuller diagnostic evaluation. A score of 3 or more “Yes” responses is the recommended threshold for a positive screen. The PC-PTSD-5 is widely used in primary care, VA systems, and community health settings due to its accuracy, brevity, and clinical practicality.
Deploy these assessments inside HiBoop
Automated delivery, scoring, and longitudinal tracking. No paper, no manual math.
Frequently Asked Questions
What is the most widely used depression screening tool?
The PHQ-9 (Patient Health Questionnaire-9) is the most widely used depression screener in the world. It has been validated in hundreds of studies across primary care, psychiatry, and telehealth settings. The PHQ-9 scores 9 items aligned with DSM-5 depression criteria on a 0–3 scale for a total score of 0–27, with a score of 10 or above indicating clinically significant depression requiring evaluation.
What is the difference between a screener and a full diagnostic assessment?
A screener identifies individuals at risk who warrant further evaluation, which is quick to administer and designed for population-level use. A full diagnostic assessment involves a thorough clinical interview using standardized criteria (e.g., DSM-5 or ICD-11) to establish a full clinical evaluation. Tools like the PHQ-9, GAD-7, and PCL-5 are validated screeners; they can support clinical decision-making but are not a substitute for a full clinical evaluation.
Are these clinical assessments validated?
Yes. All assessments in HiBoop's library are evidence-based tools with published psychometric validation studies. Each tool page includes the original validation research, sensitivity/specificity data, and clinical use guidelines.
Which assessment tools are used for PTSD screening?
The PCL-5 (PTSD Checklist for DSM-5) is the criterion standard for PTSD screening. It assesses all 20 DSM-5 PTSD symptoms across four clusters: intrusion, avoidance, negative alterations in cognition and mood, and alterations in arousal and reactivity. A total score of 31–33 or above is the provisional cutoff for PTSD. The PC-PTSD-5 is a shorter 5-item screener for primary care settings.
How long does it take to complete a clinical assessment?
Most validated brief screeners take 2 to 5 minutes to complete. The PHQ-9 and GAD-7 each run 2 to 3 minutes; the PCL-5 takes 5 to 7 minutes; the AUDIT and DAST run 2 to 4 minutes. Longer multi-domain measures like the Y-BOCS (interview-based for OCD) or the SCID-5 structured diagnostic interview can take 30 to 90 minutes. Patient-completed scales delivered by phone before the session add no clinician time and produce a scored result in the dashboard before the visit begins.
Are mental health screeners free to use?
Many of the most widely used screeners are in the public domain and free to use. PHQ-9, GAD-7, PCL-5, AUDIT, DAST-10, ASRS, MDQ, and PC-PTSD-5 are all free for clinical and research use without licensing fees. Some scales, including the Beck Depression Inventory (BDI-II), Conners 3, and many proprietary assessment batteries, are licensed and require per-administration or per-rater fees. HiBoop's library prioritizes public-domain scales so practices can administer the right tools without per-use cost.
Can patients self-administer clinical assessments?
Yes, most validated screeners are designed for self-administration on paper, web, or mobile. Self-completion is the standard delivery model for PHQ-9, GAD-7, PCL-5, AUDIT, DAST, and most brief screeners. Patient-reported scoring is consistent with clinician-administered scoring because the items are written for direct patient response. Clinician-administered scales like the HAM-D, HAM-A, and Y-BOCS exist for specific contexts where structured interview adds diagnostic value, but self-report is the dominant delivery mode in measurement-based care.